Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had revenue of $207.71M in the quarter ending March 31, 2026, with 38.63% growth. This brings the company's revenue in the last twelve months to $776.83M, up 16.29% year-over-year. In the year 2025, Supernus Pharmaceuticals had annual revenue of $718.95M with 8.63% growth.

• Revenue (ttm): $776.83M
• Revenue Growth: +16.29%
• P/S Ratio: 3.45
• Revenue / Employee: $998,500
• Employees: 778
• Market Cap: 2.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	718.95M	57.14M	8.63%
Dec 31, 2024	661.82M	54.30M	8.94%
Dec 31, 2023	607.52M	-59.72M	-8.95%
Dec 31, 2022	667.24M	87.46M	15.09%
Dec 31, 2021	579.78M	59.38M	11.41%
Dec 31, 2020	520.40M	127.64M	32.50%
Dec 31, 2019	392.76M	-16.14M	-3.95%
Dec 31, 2018	408.90M	106.66M	35.29%
Dec 31, 2017	302.24M	87.24M	40.57%
Dec 31, 2016	215.00M	67.54M	45.80%
Dec 31, 2015	147.47M	54.79M	59.12%
Dec 31, 2014	92.68M	80.66M	671.10%
Dec 31, 2013	12.02M	10.54M	712.09%
Dec 31, 2012	1.48M	677.00K	84.31%
Dec 31, 2011	803.00K	697.00K	657.55%
Dec 31, 2010	106.00K	-37.82M	-99.72%
Dec 31, 2009	37.93M	29.04M	326.65%
Dec 31, 2008	8.89M	4.66M	109.97%
Dec 31, 2007	4.23M	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error